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The combination of CEA and yGT was
particularly advantageous for separating
pelvic or local recurrence from hepatic
metastases. In the former there was a
moderate rise of CEA but little increase of
yGT whereas in hepatic metastases the
yGT was elevated. These tests, when con-
sidered with relevant clinical history, can
readily distinguish hepatic metastases from
non-malignant disease of the liver. Approxi-
mately 10% ofoutpatients whoweresymptom
free and without apparent recurrence showed
a moderate elevation (40-100 units) of yGT
without corresponding increase in CEA,
when examined 3 months to 13 years after
excision of the primary. The significance of
this biochemical abnormality is, as yet,
unknown.
A COMPARISON OF PHOSPHATE
BONE SCANNING AGENTS IN
HUMAN MALIGNANT DISEASE, D.
L. Citrin, R. Bessent, J. Tuohy, P. Crumlish,
W. R. Greig and L. H. Blumgart, University
Department of Medicine and Surgery, De-
partments of Nuclear Medicine and Radio-
logy, Royal Infirmary, Glasgow, and Depart-
ment ofClinical Physics and Bio-Engineering,
Western Regional Hospital Board, Glasgow.
Bone scanning is recognized to be more
effective than radiology in the demonstration
of skeletal metastases. The established bone
scanning agents, strontium-87m and fluorine-
18, are not entirely satisfactory. Recently,
technetium labelled phosphate compounds-
polyphosphate, pyrophosphate and ethane
hydroxy diphosphonate-have become avail-
able for skeletal scanning. We have now
performed over 200 consecutive studies in
man and no toxic effects have been noted. A
study of the relative efficacy of these agents
in patients with metastatic disease, and in
normal subjects, is described. Adequate
visualization of the skeleton has been
obtained and comparison of the scans and
x-rays suggests that these compounds are of
definite value in the investigation of malig-
nant disease of the skeleton.
THE RELATIONSHIP BETWEEN
CELL SURVIVAL, CHROMOSOME
ABERRATIONS AND DNA REPAIR
IN TUMOUR CELL LINES OF DIFFER-
ENTIAL SENSITIVITY TO X-RAYS
AND SULPHUR MUSTARD, D. Scott,
M. Fox and B. W. Fox, Paterson Labora-
tories, Christie Hospital, Manchester.
Cultured Yoshida lymphosarcoma cells
resistant (R) to treatment with sulphur
mustard suffered much less chromosome
damage than sensitive (S) cells in spite of
equal alkylation of DNA, RNA and protein
in R and S cells. The R and S cell lines were
equally sensitive to x-rays and sustained the
same amount of chromosome damage. DNA
repair synthesis was equal in R and S cells
after sulphur mustard or x-ray treatment.
Much less chromosome damage was
found in L5178Y mouse lymphoma cells
resistant to x-irradiation than in radiation-
sensitive cells but the amount of DNA
repair was similar.
Thus, drug and radiation resistance is
accompanied by, and perhaps mediated
through, a reduced amount of induced
chromosome damage but is not quantitatively
related to DNA repair capacity.
MECHANISM OF ACTION STUDIES
WITH IRCF 159: EFFECTS ON THE
GROWTH AND MORPHOLOGY OF
BHK-21S CELLS, T. C. Stephens and
A. M. Creighton, Imperial Cancer Research
Fund, London.
The effects of IRCF 159 on macro-
molecular synthesis in cultured cells led to the
suggestion of a possible radiomimetic action
(Creighton and Birnie, Int. J. Cancer, 1970,
5, 47). We have found a dose-dependent
inhibition of the growth (cell numbers) of
BHK-21S cells approaching 100% at >100
,umol/l (27 ug/ml). Continuous exposure to a
range of doses >5 ,tmol/l produced a hyper-
bolic decrease in survival (colony forming
assay). Such a response is generally asso-
ciated with antimetabolites but in this case
the hyperbolic curve seems more likely to be
caused by a protective effect which is seen
with ICRF 159 at high doses (ca. 400 tzmol/l).
Time lapse cinemicrography has shown
that the increase in cell numbers is inhibited
due to an interference with cytokinesis.
However, the cells continue to grow and
accumulate DNA, RNA and protein and
many become multinucleate. Comparative
studies indicate that this cell line is parti-
cularly sensitive in this respect. Cells with
a similar multinucleate morphology were
obtainedfollowing treatment withx-radiation100 B.A.C.R. AUTUMN MEETING
or alkylating agents but not with a variety
of other cytotoxic agents.
THE RESPONSE TO CHEMOTHERA-
PEUTIC AGENTS OF MOUSE
TUMOUR CELLS IN THE EXPONEN-
TIAL AND STATIONARY PHASES
OF GROWTH, P. R. Twentyman and
N. M. Bleehen, Academic Department of
Radiotherapy, The Middlesex Hospital,
London.
Cells growing in monolayer culture pass
from a period of exponential growth into a
stationary (or plateau) phase. This phase is
characterized by a reduction in the tritiated
thymidine labelling index, an increase in the
cell cycle time and a large proportion of cells
which are " out of cycle " (Hahn and Little,
Curr. Topics Radiat. Res., 1972, 8, 39). There
is therefore a similarity between stationary
phase cultures and solid tumours which also
contain "non-cycling " cells.
Dose-response curves are presented for
the effect of a number of chemotherapeutic
agents on EMT6 mouse tumour cells in
exponential and stationary phases of growth.
The similarities and differences between our
results and those of other workers are
discussed.
EVIDENCE OF CLUSTERING IN
CASES OF GASTROINTESTINAL
TRACT MALIGNANCY, R. Bedwani,
C. R. GillisandJ. A. H. Waterhouse, Regional
Cancer Registry, Birmingham, and Depart-
ment of Epidemiology and Preventive Medi-
cine, University of Glasgow.
Arecent studyin Ayrshire (Gillis, McClean
and Bedwani, 1973, in the press) has shown
evidence of clustering of cases of gastro-
intestinal tract cancers compared with certain
other sites. The county of Herefordshire in
the Birmingham region was selected for a
comparative study. The preliminary results
of this investigation show, for the same
measure of maximal separation within a
cluster (200 metres), the degrees of clustering
which are similar to those for Ayrshire.
They are headed by the gastrointestinal tract
sites at 92.2%, bronchus at 82.5%, female
breasts at77.0% to female genitalia at 66.0%.
More detailed positional analyses have been
made which will be assessed by computer
randomization procedures.
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